RNAC
RNAC
NASDAQ · Biotechnology

Cartesian Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks
$6.49
+0.21 (+3.34%)
As of Feb 8, 2:07 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 3 20%
Sell 0 0%
Price Target
Analyst Price Target +526.5% upside
Low Target $22.44
Average Target $40.66
High Target $45.57
Current Price $6.49
Current
$6.49
Target
$40.66
$22.44 $40.66 avg $45.57
Scenario Analysis
Bear Case
$22.44
245.8%
Low target
Base Case
$40.66
+526.5%
Avg target
Bull Case
$45.57
+602.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$39.19
-83.4% from high
52-Week Low
$27.12
+-76.1% from low
Target vs 52W High
$40.66
+3.8% vs high
Next Earnings Report
Mar 5, 2026 · After Market Close
17d
until earnings
EPS Est: $-0.87
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%